CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

147 hedge funds and large institutions have $358M invested in Clovis Oncology, Inc. in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

28% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 50

Holders
147
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$114M
Puts
$118M
Net Calls
Net Calls Change

Top Buyers

1 +$27.8M
2 +$6.55M
3 +$5.21M
4
PAI
Palo Alto Investors
California
+$3.5M
5
Jane Street
Jane Street
New York
+$2.54M

Top Sellers

1 -$26M
2 -$15.7M
3 -$15.2M
4
RG
Redmile Group
California
-$14.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$13.9M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$2.17M
27
$2.17M
28
$2.14M
29
$2.07M
30
$2.06M
31
$2.01M
32
$1.86M
33
$1.56M
34
$1.55M
35
$1.53M
36
$1.52M
37
$1.49M
38
$1.42M
39
$1.25M
40
$1.24M
41
$1.23M
42
$1.19M
43
$1.11M
44
$1.06M
45
$1.04M
46
$973K
47
$891K
48
$846K
49
$845K
50
$818K